Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines
Frontiers in Cellular and Infection Microbiology · 25.05.2023 · 13
DOI: 10.3389/fcimb.2023.1195314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 25.05.2023. Verfasst von Mengsu Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Francisella tularensis, Tularemia, Adenoviruses, Human. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tularemia is a highly contagious disease caused by infection with Francisella tularensis ( Ft ), a pathogenic intracellular gram-negative bacterium that infects a wide range of animals and causes severe disease and death in people, making it a public health concern. Vaccines are the most effective way to prevent tularemia. However, there are no Food and Drug Administration (FDA)-approved Ft vaccines thus far due to safety concerns. Herein, three membrane proteins of Ft , Tul4, OmpA, and FopA, and a molecular chaperone, DnaK, were identified as potential protective antigens using a multifactor protective antigen platform. Moreover, the recombinant DnaK, FopA, and Tul4 protein vaccines elicited a high level of IgG antibodies but did not protect against challenge. In contrast, protective immunity was elicited by a replication-defective human type 5 adenovirus (Ad5) encoding the Tul4, OmpA, FopA, and DnaK proteins (Ad5-Tul4, Ad5-OmpA, Ad5-FopA, and Ad5-DnaK) after a single immunization, and all Ad5-based vaccines stimulated a Th1-biased immune response. Moreover, intramuscular and intranasal vaccination with Ad5-Tul4 using the prime-boost strategy effectively eliminated Ft lung, spleen and liver colonization and provided nearly 80% protection against intranasal challenge with the Ft live vaccine strain (LVS). Only intramuscular, not intranasal vaccination, with Ad5-Tul4 protected mice from intraperitoneal challenge. This study provides a comprehensive comparison of protective immunity against Ft provided by subunit or adenovirus-vectored vaccines and suggests that mucosal vaccination with Ad5-Tul4 may yield desirable protective efficacy against mucosal infection, while intramuscular vaccination offers greater overall protection against intraperitoneal tularemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China.
Zitieren
APA
Zhao, M., Zhai, Y., Zai, X., Mao, Y., Hu, E., Wei, Z., Li, Y., Li, K., Liu, Y., Xu, J., Yu, R., & Chen, W. (2023). Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1195314
Vancouver
Zhao M, Zhai Y, Zai X, Mao Y, Hu E, Wei Z, et al. Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1195314
BibTeX
@article{Zhao2023,
author = {Zhao, Mengsu and Zhai, Yanfang and Zai, Xiaodong and Mao, Yunyun and Hu, Enbo and Wei, Zhaodong and Li, Yan and Li, Kai and Liu, Yanhong and Xu, Junjie and Yu, Rui and Chen, Wei},
title = {Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
volume = {13},
doi = {10.3389/fcimb.2023.1195314}
}
EUVIMED